TBPH: Theravance Biopharma Inc

TBPH新闻

• 14:35 Down 30.6% in 4 Weeks, Here's Why You Should You Buy the Dip in Theravance Bio (TBPH)
• 16:24 Oppenheimer因三期临床试验失败下调Theravance Biopharma股票评级
• 16:22 Oppenheimer downgrades Theravance Biopharma stock rating on Phase 3 miss
• 15:34 TBPH Stock Plunges 26% on Failure of Late-Stage MSA Study
• 08:04 B.Riley因临床试验失败下调Theravance Biopharma股票评级
• 08:03 B.Riley cuts Theravance Biopharma stock rating on trial failure
• 19:01 Micron and MongoDB among market cap stock movers on Tuesday
• 17:42 BTIG因试验失败下调Theravance Biopharma目标价
• 17:41 BTIG cuts Theravance Biopharma stock price target on trial miss
• 17:14 The Excruciating Failure That Could Cause Theravance, Down 27%, To Sell Itself
• 15:31 Micron, Intel among market cap stock movers on Tuesday
• 15:19 Theravance Biopharma股价因试验失败而暴跌
• 15:17 Theravance Biopharma stock tumbles after trial failure
• 13:39 Theravance因药物试验未达主要终点而削减60%成本
• 13:37 Theravance to cut costs 60% after drug trial fails primary endpoint
• 13:19 Theravance Biopharma Plummets As Phase 3 Study Falls Short - Theravance Biopharma (NASDAQ:TBPH)
• 12:52 H.C. Wainwright上调Theravance Biopharma目标价,因试验进展良好
• 12:49 H.C. Wainwright raises Theravance Biopharma price target on trial progress
• 13:02 CRMD vs. TBPH: Which Small-Cap Biotech Stock Is the Better Bet?
• 18:15 Is the Options Market Predicting a Spike in Theravance Biopharma Stock?
• 14:50 Why Theravance Biopharma (TBPH) is a Top Momentum Stock for the Long-Term
• 19:48 Theravance Biopharma股票创52周新高至21.01美元
• 19:47 Theravance Biopharma stock hits 52-week high at $21.01
• 14:45 Why Theravance Biopharma (TBPH) is a Top Growth Stock for the Long-Term